McKinley Capital Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $2.45M | Sell |
23,015
-54
| -0.2% | -$5.42K | 0.43% | 59 |
|
|
2024
Q1 | $2.23M | Buy |
23,069
+5,931
| +35% | +$608K | 0.27% | 99 |
|
|
2023
Q4 | $1.73M | Sell |
17,138
-390
| -2% | -$37.6K | 0.22% | 104 |
|
|
2023
Q3 | $1.79M | Buy |
17,528
+1,312
| +8% | +$133K | 0.25% | 102 |
|
|
2023
Q2 | $1.64M | Sell |
16,216
-268
| -2% | -$26.8K | 0.22% | 107 |
|
|
2023
Q1 | $1.52M | Sell |
16,484
-318
| -2% | -$27.8K | 0.2% | 110 |
|
|
2022
Q4 | $1.52M | Sell |
16,802
-117
| -0.7% | -$9.86K | 0.2% | 110 |
|
|
2022
Q3 | $1.29M | Sell |
16,919
-24
| -0.1% | -$1.99K | 0.17% | 119 |
|
|
2022
Q2 | $1.43M | Sell |
16,943
-188
| -1% | -$16.5K | 0.19% | 118 |
|
|
2022
Q1 | $1.5M | Sell |
17,131
-821
| -5% | -$71.1K | 0.15% | 123 |
|
|
2021
Q4 | $1.57M | Sell |
17,952
-638
| -3% | -$53K | 0.14% | 128 |
|
|
2021
Q3 | $1.52M | Sell |
18,590
-730
| -4% | -$65.7K | 0.14% | 127 |
|
|
2021
Q2 | $1.76M | Sell |
19,320
-323
| -2% | -$28.8K | 0.12% | 128 |
|
|
2021
Q1 | $1.68M | Sell |
19,643
-224
| -1% | -$20.1K | 0.13% | 130 |
|
|
2020
Q4 | $1.88M | Sell |
19,867
-546
| -3% | -$47.7K | 0.13% | 126 |
|
|
2020
Q3 | $1.77M | Sell |
20,413
-906
| -4% | -$78.5K | 0.14% | 121 |
|
|
2020
Q2 | $1.86M | Sell |
21,319
-1,570
| -7% | -$136K | 0.13% | 119 |
|
|
2020
Q1 | $1.89M | Sell |
22,889
-712
| -3% | -$63.5K | 0.15% | 108 |
|
|
2019
Q4 | $2.23M | Buy |
23,601
+14,188
| +151% | +$1.27M | 0.15% | 114 |
|
|
2019
Q3 | $818K | Sell |
9,413
-227
| -2% | -$20.4K | 0.06% | 130 |
|
|
2019
Q2 | $880K | Sell |
9,640
-3,472
| -26% | -$294K | 0.06% | 160 |
|
|
2019
Q1 | $1.13M | Sell |
13,112
-769
| -6% | -$61.7K | 0.08% | 125 |
|
|
2018
Q4 | $1.07M | Buy |
+13,881
| New | +$1.08M | 0.09% | 124 |
|
|
2017
Q1 | – | Sell |
-19,143
| Closed | -$1.25M | – | 538 |
|
|
2016
Q4 | $1.25M | Sell |
19,143
-2,121
| -10% | -$138K | 0.05% | 224 |
|
|
2016
Q3 | $1.5M | Sell |
21,264
-1,081
| -5% | -$78.8K | 0.05% | 217 |
|
|
2016
Q2 | $1.65M | Buy |
22,345
+910
| +4% | +$62.9K | 0.08% | 204 |
|
|
2016
Q1 | $1.39M | Buy |
21,435
+5,045
| +31% | +$343K | 0.07% | 205 |
|
|
2015
Q4 | $1.26M | Sell |
16,390
-8,630
| -34% | -$686K | 0.06% | 207 |
|
|
2015
Q3 | $2.06M | Buy |
25,020
+488
| +2% | +$43.4K | 0.1% | 179 |
|
|
2015
Q2 | $2.16M | Sell |
24,532
-2,630
| -10% | -$241K | 0.09% | 194 |
|
|
2015
Q1 | $2.4M | Sell |
27,162
-389
| -1% | -$34.5K | 0.1% | 187 |
|
|
2014
Q4 | $2.29M | Buy |
27,551
+203
| +0.7% | +$16.8K | 0.09% | 180 |
|
|
2014
Q3 | $2.31M | Buy |
27,348
+25,990
| +1,914% | +$2.1M | 0.1% | 168 |
|
|
2014
Q2 | $110K | Buy |
+1,358
| New | +$107K | ﹤0.01% | 324 |
|
Other funds holding NVS
CCM
McKinley Capital Management's NVS Position: Q2 2024 in Review
McKinley Capital Management reduced its Novartis (NVS) stake by 0.23% in Q2 2024, selling an estimated $5.42K and leaving 23,015 shares worth $2.45M. The position accounts for 0.43% of the portfolio, ranked #59.
McKinley Capital Management first reported a position in NVS in Q2 2014 and has held it in 34 quarters since. 1,306 funds tracked by Wall St. Rank hold NVS as of Q2 2024.
- McKinley Capital Management held 23,015 shares of Novartis worth $2.45M as of Q2 2024.
- McKinley Capital Management sold 54 Novartis shares in Q2 2024, an estimated $5.42K.
- Novartis made up 0.43% of McKinley Capital Management's portfolio in Q2 2024, its #59 holding.
- McKinley Capital Management first reported a position in Novartis in Q2 2014 and has held it in 34 quarters since.
- 1,306 funds tracked by Wall St. Rank held Novartis as of Q2 2024.
Based on McKinley Capital Management's 13F filing for Q2 2024, filed 12 Aug 2024.